Hologic Announces FDA Approval of Aptima® CMV Quant Assay for Human Cytomegalovirus

MARLBOROUGH, Mass.–(BUSINESS WIRE)– #Aptima–Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) approved its Aptima CMV Quant assay to quantify the viral load of cytomegalovirus (CMV) in patients who have had solid organ or stem cell transplants. The test is the first to be introduced in the U.S. by Hologic for post-transplant pathogen detection and monitoring on Hologic’s fully automated Panther® system, and joins the existing portfolio of diagnostic and vira
Click here to view original post